![[HTML version]](/e/graphics/htmlborder.gif)
![[PDF version]](/e/graphics/pdfborder.gif)
![[CIF]](/e/graphics/cifborder.gif)
![[3d view]](/e/graphics/3dviewborder.gif)
![[Structure Factors]](/e/graphics/structurefactorsborder.gif)
![[CIF check Report]](/e/graphics/checkcifborder.gif)
![[Buy article online]](/logos/buy.gif)
![[Contents scheme]](nc6001contents.gif)
Acta Cryst. (2004). E60, o1989-o1991 [ doi:10.1107/S1600536804024894 ]
Abstract: The title compound, C24H31N2O2+·Cl-, is a potential drug designed as a hybrid molecule with antihypertensive, antioxidant and
-adrenolytic activity. It contains nearly planar benzofuran and benzene ring systems, and a piperazine ring which adopts an almost perfect chair conformation.
Online 16 October 2004
Copyright © International Union of Crystallography
IUCr Webmaster